Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,272 | 400 | 83.4% |
| Education | $1,235 | 23 | 14.2% |
| Travel and Lodging | $107.81 | 1 | 1.2% |
| Consulting Fee | $100.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $2,271 | 119 | $0 (2024) |
| Antares Pharma, Inc. | $925.91 | 52 | $0 (2024) |
| PFIZER INC. | $698.22 | 38 | $0 (2024) |
| Janssen Biotech, Inc. | $473.00 | 22 | $0 (2023) |
| COLOPLAST CORP | $399.88 | 20 | $0 (2024) |
| Myovant Sciences Inc. | $304.98 | 16 | $0 (2022) |
| DENTSPLY IH Inc. | $288.89 | 23 | $0 (2021) |
| Sumitomo Pharma America, Inc. | $250.22 | 12 | $0 (2024) |
| Teleflex LLC | $241.07 | 2 | $0 (2024) |
| TOLMAR Pharmaceuticals, Inc. | $204.12 | 11 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,190 | 41 | Astellas Pharma US Inc ($244.36) |
| 2023 | $1,545 | 64 | Astellas Pharma US Inc ($458.41) |
| 2022 | $1,334 | 68 | Astellas Pharma US Inc ($272.76) |
| 2021 | $1,777 | 94 | Astellas Pharma US Inc ($343.15) |
| 2020 | $720.71 | 44 | Astellas Pharma US Inc ($206.35) |
| 2019 | $913.42 | 53 | TherapeuticsMD, Inc. ($160.94) |
| 2018 | $361.11 | 20 | Astellas Pharma US Inc ($333.41) |
| 2017 | $873.50 | 41 | Astellas Pharma US Inc ($260.51) |
All Payment Transactions
425 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $51.88 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/23/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $189.19 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/12/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $90.61 | General |
| Category: LithoVue_URO | ||||||
| 08/30/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Oncology | ||||||
| 08/23/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Continence Care | ||||||
| 08/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: HORMONE THERAPY | ||||||
| 08/13/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Oncology | ||||||
| 08/06/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $77.97 | General |
| 07/29/2024 | Agiliti Surgical, Inc. | Koelis Trinity Fusion Biopsy System (Device) | Food and Beverage | Cash or cash equivalent | $31.44 | General |
| Category: Surgical Lasers | ||||||
| 07/19/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/21/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Oncology | ||||||
| 06/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: ONCOLOGY | ||||||
| 06/03/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: HORMONE THERAPY | ||||||
| 05/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: HORMONE THERAPY | ||||||
| 05/24/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/20/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 05/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $34.31 | General |
| Category: HORMONE THERAPY | ||||||
| 04/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: ONCOLOGY | ||||||
| 04/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 04/19/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $25.12 | General |
| 04/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: HORMONE THERAPY | ||||||
| 04/15/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $24.69 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 04/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,192 | 1,491 | $413,836 | $112,965 |
| 2022 | 15 | 1,353 | 1,810 | $552,079 | $140,641 |
| 2021 | 18 | 1,219 | 1,624 | $558,687 | $132,604 |
| 2020 | 22 | 1,202 | 3,965 | $461,761 | $137,171 |
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 273 | 352 | $129,350 | $33,520 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 349 | 482 | $123,569 | $33,303 | 27.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 84 | 106 | $70,278 | $22,169 | 31.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $39,411 | $10,038 | 25.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 68 | 68 | $21,872 | $6,038 | 27.6% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 15 | 15 | $10,725 | $2,923 | 27.3% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 15 | 15 | $1,920 | $1,539 | 80.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 109 | 132 | $8,580 | $1,176 | 13.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 66 | 77 | $2,632 | $874.01 | 33.2% |
| 51700 | Simple bladder irrigation and/or instillation | Office | 2023 | 11 | 13 | $3,523 | $871.00 | 24.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 123 | 152 | $1,976 | $514.91 | 26.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 309 | 405 | $142,563 | $40,414 | 28.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 318 | 411 | $100,615 | $26,199 | 26.0% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 82 | 102 | $64,844 | $20,985 | 32.4% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 14 | 116 | $98,600 | $16,021 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $41,331 | $10,661 | 25.8% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2022 | 13 | 13 | $30,952 | $7,694 | 24.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $14,905 | $3,917 | 26.3% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 21 | 21 | $14,471 | $3,908 | 27.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2022 | 21 | 21 | $2,592 | $2,035 | 78.5% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2022 | 11 | 34 | $8,383 | $1,862 | 22.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 149 | 204 | $12,801 | $1,756 | 13.7% |
| 51741 | Electronic assessment of bladder emptying | Office | 2022 | 83 | 101 | $3,298 | $1,055 | 32.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 15 | $3,744 | $1,054 | 28.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 12 | 12 | $3,860 | $926.98 | 24.0% |
About Dr. Stephen Yu, M.D
Dr. Stephen Yu, M.D is a Urology healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497727978.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Yu, M.D has received a total of $8,715 in payments from pharmaceutical and medical device companies, with $1,190 received in 2024. These payments were reported across 425 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($7,272).
As a Medicare-enrolled provider, Yu has provided services to 4,966 Medicare beneficiaries, totaling 8,890 services with total Medicare billing of $523,381. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Orlando, FL
- Active Since 02/07/2006
- Last Updated 09/17/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1497727978
Products in Payments
- XTANDI (Drug) $1,096
- XYOSTED (Drug) $499.81
- ORGOVYX (Drug) $486.13
- Xtandi (Drug) $428.46
- NOCDURNA (Drug) $342.09
- LoFric (Device) $341.04
- ERLEADA (Drug) $288.39
- GEMTESA (Drug) $270.17
- ELIGARD (Drug) $258.39
- UROLIFT (Device) $241.07
- Myrbetriq (Drug) $238.84
- INTERSTIM (Device) $226.73
- SpeediCath (Device) $185.29
- MYRBETRIQ (Drug) $184.01
- Natesto (Drug) $178.17
- CONTINENCE CARE (Device) $134.52
- ProACT (Device) $133.00
- Da Vinci Surgical System (Device) $107.81
- Nubeqa (Drug) $104.22
- KEYTRUDA (Biological) $100.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Orlando
Dr. Olubayo Tojuola, M.d, M.D
Urology — Payments: $213,572
Jeffrey Brady, M.d, M.D
Urology — Payments: $135,720
Dr. Lucas Wiegand, Md, MD
Urology — Payments: $103,853
Albert Ong, M.d, M.D
Urology — Payments: $86,166
Christopher Russell, Md, MD
Urology — Payments: $24,045
Stephen Baker, Md, MD
Urology — Payments: $20,508